Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.
Johnson RM, Phillips HS, Bais C, Brennan CW, Cloughesy TF, Daemen A, Herrlinger U, Jenkins RB, Lai A, Mancao C, Weller M, Wick W, Bourgon R, Garcia J.
Johnson RM, et al. Among authors: lai a.
Neuro Oncol. 2020 Dec 18;22(12):1742-1756. doi: 10.1093/neuonc/noaa157.
Neuro Oncol. 2020.
PMID: 32897363
Free PMC article.